The MTT cell proliferation assay demonstrated that lowering KAP1 expression significantly inhibited ovarian cancer cell growth by 50% in the SKOV3 siKAP1 group (p < 0.01), and 60% in the A2780 siKAP1 group (p < 0.001) when compared with the control group (Figure 5B and Figure 6B). Here, TRIM28 is linked to ovarian cancer.